| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 5.69× | 5.69× | 5.34× | 6.17× | 9.28× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 524.31× | 524.31× | — | — | — | ||
| −518.62× | −518.62× | — | — | — | ||
| −0.90× | −0.93× | — | — | — | ||
| 0.17× | 0.17× | 0.17× | 0.15× | 0.11× | ||
| 6.45× | 6.45× | — | — | — | ||
| −1.65× | −1.65× | — | — | — |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 9.28 | 6.17 | 5.34 | 5.69 | 5.69 | |
| Payable Days (DPO) | — | — | — | 524.31 | 524.31 | |
| Cash Conversion Cycle (days) | — | — | — | -518.62 | -518.62 | |
| Working Capital Turnover | — | — | — | -0.93 | -0.90 | |
| Asset Turnover | 0.11 | 0.15 | 0.17 | 0.17 | 0.17 | |
| Cash Conversion (CFO/Net Income) | — | — | — | 6.45 | 6.45 | |
| CFO/EBITDA | — | — | — | -1.65 | -1.65 |